Tolvaptan

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1720 publications

A highly sensitive LC-MS/MS method for quantification of AB-38b in rat plasma, liver and kidney tissues: application to a pharmacokinetic study.

A highly sensitive LC-MS/MS method for quantification of AB-38b in rat plasma, liver and kidney tissues: application to a pharmacokinetic study.

Journal: Analytical methods : advancing methods and applications

Published: January 12, 2026

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: November 29, 2025

Real-world evidence for using urine osmolality as a practical tool in tolvaptan dose optimization in patients with ADPKD.

Real-world evidence for using urine osmolality as a practical tool in tolvaptan dose optimization in patients with ADPKD.

Journal: Clinical nephrology

Published: November 27, 2025

Hyponatraemia and cancer.

Hyponatraemia and cancer.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: November 13, 2025

Tolvaptan versus other interventions for hyponatraemia in people with cirrhosis.

Tolvaptan versus other interventions for hyponatraemia in people with cirrhosis.

Journal: The Cochrane database of systematic reviews

Published: November 10, 2025

Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review.

Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review.

Journal: Renal failure

Published: November 10, 2025

Decoding Hyponatremia: A Systematic Review of Diagnostic Pathways and Therapeutic Approaches Applied When Correction Fails.

Decoding Hyponatremia: A Systematic Review of Diagnostic Pathways and Therapeutic Approaches Applied When Correction Fails.

Journal: Cureus

Published: November 05, 2025

Assessing ciliary function in polycystic kidney disease: beyond the kidney.

Assessing ciliary function in polycystic kidney disease: beyond the kidney.

Journal: Acta clinica Belgica

Published: October 29, 2025

Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor.

Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor.

Journal: Computers in biology and medicine

Published: October 23, 2025

Thirst in heart failure: a neglected symptom with profound implications for patient management and quality of life.

Thirst in heart failure: a neglected symptom with profound implications for patient management and quality of life.

Journal: Expert review of cardiovascular therapy

Published: October 18, 2025

Tolvaptan: a potential rescue therapy for SIADH with refractory hyponatremia associated with acute intermittent porphyria.

Tolvaptan: a potential rescue therapy for SIADH with refractory hyponatremia associated with acute intermittent porphyria.

Journal: Journal of pediatric endocrinology & metabolism : JPEM

Published: October 04, 2025

Refractory SIAD Triggered by Herpes Zoster Ophthalmicus: Impact of Postherpetic Neuralgia on Hyponatremia Duration and the Role of Tolvaptan-A Case Report.

Refractory SIAD Triggered by Herpes Zoster Ophthalmicus: Impact of Postherpetic Neuralgia on Hyponatremia Duration and the Role of Tolvaptan-A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: October 01, 2025

Showing 1-12 of 1,720

Last Updated: 02/24/2026